by GCP Central | Dec 12, 2022 | GCP Central Products
In this guest blog from Esther Daemen, we look at the need for the involvement of clinical experts in developing new medical devices, from concept to completion, and the importance of adhering to the new Medical Device Regulation (MDR). Clinical evaluation is an...
by GCP Central | Nov 21, 2022 | GCP Central News
This is the third and final part of a series of articles where GCP Central goes in-depth into the challenges, learnings, and critical findings of implementing the new European Clinical Trials Regulation (EU CTR). In this instalment, we look at issues encountered in...
by GCP Central | Nov 7, 2022 | GCP Central News
This is the second in a series of articles where GCP Central goes in-depth into the challenges, learnings, and critical findings of implementing the new European Clinical Trials Regulation (EU CTR). In this installment, we look at transparency and publishing clinical...
by GCP Central | Oct 25, 2022 | GCP Central News
This is the first in a series of articles where GCP Central goes in-depth into the challenges, learnings, and critical findings of implementing the new European Clinical Trials Regulation (EU CTR). In this instalment, we reflect on the Clinical Trials Information...
by GCP Central | Jul 15, 2022 | GCP Central News, updates law & regulations
In the past few months, 2 new regulations have been put into place in the world of clinical trials. The EU Clinical Trials Regulation and the Medical Devices Regulation (MDR) (EU 2017/745) have been implemented. This has created a new need for training teams to...
by GCP Central | Mar 30, 2022 | GCP Central Products
The transition from the previous MDD to the new MDR brings a period of change. But what impact will this have on research and more importantly, what are the issues faced with non-compliance? With over 20 years of industry experience in biotech, pharma, and medical...
